[Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].


BACKGROUND Almotriptan, the most recent drug of the triptan family, has shown good efficacy and tolerability profile in clinical trials. OBJECTIVE To assess almotriptan's tolerability and effectiveness in the setting of routine clinical practice. PATIENTS AND METHODS 1,643 patients diagnosed of migraine according to IHS criteria were recruited by 317… (More)